Search Results

There are 24502 results for: content related to: Early factor VIII exposure and subsequent inhibitor development in children with severe haemophilia A

  1. Achievements, challenges and unmet needs for haemophilia patients with inhibitors

    Haemophilia

    Volume 22, Issue S1, January 2016, Pages: 1–24, Y. Dargaud, A. Pavlova, S. Lacroix-Desmazes, K. Fischer, M. Soucie, S. Claeyssens, D.w. Scott, R. d'Oiron, G. Lavigne-Lissalde, G. Kenet, C. Escuriola Ettingshausen, A. Borel-Derlon, T. Lambert, G. Pasta and C. Négrier

    Version of Record online : 5 JAN 2016, DOI: 10.1111/hae.12860

  2. You have free access to this content
    Source and purity of factor VIII products as risk factors for inhibitor development in patients with hemophilia A

    Journal of Thrombosis and Haemostasis

    Volume 10, Issue 5, May 2012, Pages: 781–790, M. E. MANCUSO, P. M. MANNUCCI, A. ROCINO, I. GARAGIOLA, A. TAGLIAFERRI and E. SANTAGOSTINO

    Version of Record online : 2 MAY 2012, DOI: 10.1111/j.1538-7836.2012.04691.x

  3. You have free access to this content
    Induction of partial immune tolerance to factor VIII through prior mucosal exposure to the factor VIII C2 domain

    Journal of Thrombosis and Haemostasis

    Volume 4, Issue 10, October 2006, Pages: 2172–2179, F. E. RAWLE, K. P. PRATT, A. LABELLE, H. L. WEINER, C. HOUGH and D. LILLICRAP

    Version of Record online : 5 JUL 2006, DOI: 10.1111/j.1538-7836.2006.02118.x

  4. You have free access to this content
    Novel investigations on the protective role of the FVIII/VWF complex in inhibitor development

    Haemophilia

    Volume 20, Issue s6, September 2014, Pages: 2–16, P. M. Mannucci, Q. Shi, S. Bonanad and R. Klamroth

    Version of Record online : 26 JUN 2014, DOI: 10.1111/hae.12465

    Corrected by:

    Erratum: Erratum

    Vol. 20, Issue 5, e376, Version of Record online: 28 AUG 2014

  5. You have free access to this content
    Dangerous liaisons: how the immune system deals with factor VIII

    Journal of Thrombosis and Haemostasis

    Volume 11, Issue 1, January 2013, Pages: 47–55, A. WROBLEWSKA, B. M. REIPERT, K. P. PRATT and J. VOORBERG

    Version of Record online : 27 JAN 2013, DOI: 10.1111/jth.12065

  6. You have free access to this content
    Factor VIII-specific B cell responses in haemophilia A patients with inhibitors

    Haemophilia

    Volume 16, Issue 102, May 2010, Pages: 35–43, P. M. W. Van HELDEN, S. D. VAN HAREN, K. FIJNVANDRAAT, H. MARIJKE van den BERG and J. VOORBERG

    Version of Record online : 23 APR 2010, DOI: 10.1111/j.1365-2516.2010.02215.x

  7. Relationships between factor VIII:Ag and factor VIII in recombinant and plasma-derived factor VIII concentrates

    Haemophilia

    Volume 10, Issue 5, September 2004, Pages: 459–469, Y. Lin, X. Yang, M.-C. Chevrier, S. Craven, T. W. Barrowcliffe, R. Lemieux and F. A. Ofosu

    Version of Record online : 12 AUG 2004, DOI: 10.1111/j.1365-2516.2004.00957.x

  8. You have free access to this content
    Mild hemophilia A patient with novel Pro1809Leu mutation develops an anti-C2 antibody inhibiting allogeneic but not autologous factor VIII activity

    Journal of Thrombosis and Haemostasis

    Volume 13, Issue 10, October 2015, Pages: 1843–1853, K. Yada, K. Nogami, M. Takeyama, K. Ogiwara, H. Wakabayashi and M. Shima

    Version of Record online : 23 SEP 2015, DOI: 10.1111/jth.13118

  9. You have free access to this content
    Surgery and inhibitor development in hemophilia A: a systematic review

    Journal of Thrombosis and Haemostasis

    Volume 9, Issue 10, October 2011, Pages: 1948–1958, C. L. ECKHARDT, J. G. van der BOM, M. VAN DER NAALD, M. PETERS, P. W. KAMPHUISEN and K. FIJNVANDRAAT

    Version of Record online : 29 SEP 2011, DOI: 10.1111/j.1538-7836.2011.04467.x

  10. You have free access to this content
    Pathogenic antibodies to coagulation factors. Part one: Factor VIII and Factor IX

    Journal of Thrombosis and Haemostasis

    Volume 2, Issue 7, July 2004, Pages: 1082–1095, P. Lollar

    Version of Record online : 23 JUN 2004, DOI: 10.1111/j.1538-7836.2004.00802.x

  11. You have free access to this content
    Intensive exposure to factor VIII is a risk factor for inhibitor development in mild hemophilia A

    Journal of Thrombosis and Haemostasis

    Volume 1, Issue 6, June 2003, Pages: 1228–1236, A. Sharathkumar, D. Lillicrap, V. S. Blanchette, M. Kern, J. Leggo, A. M. Stain, L. Brooker and M. D. Carcao

    Version of Record online : 21 MAY 2003, DOI: 10.1046/j.1538-7836.2003.00230.x

  12. You have free access to this content
    Inhibitor incidence after intensive FVIII replacement for surgery in mild and moderate haemophilia A: a prospective national study in the Netherlands

    British Journal of Haematology

    Volume 157, Issue 6, June 2012, Pages: 747–752, Corien L. Eckhardt, Evelien P. Mauser-Bunschoten, Marjolein Peters, Frank W. G. Leebeek, Felix J. M. van der Meer and Karin Fijnvandraat

    Version of Record online : 26 APR 2012, DOI: 10.1111/j.1365-2141.2012.09119.x

  13. Heterogeneity of the immune response to adenovirus-mediated factor VIII gene therapy in different inbred hemophilic mouse strains

    The Journal of Gene Medicine

    Volume 6, Issue 12, December 2004, Pages: 1358–1368, Fiona E. M. Rawle, Chang Xin Shi, Brian Brown, Alexis McKinven, Shawn Tinlin, Frank L. Graham, Christine Hough and David Lillicrap

    Version of Record online : 18 OCT 2004, DOI: 10.1002/jgm.624

  14. Risk of inhibitor development in mild haemophilia A increases with age

    Haemophilia

    Volume 18, Issue 2, March 2012, Pages: 263–267, E. P. MAUSER-BUNSCHOTEN, I. E. M DEN UIJL, R. E. G SCHUTGENS, G. ROOSENDAAL and K. FISCHER

    Version of Record online : 19 AUG 2011, DOI: 10.1111/j.1365-2516.2011.02629.x

  15. You have free access to this content
    Inhibitors – genetic and environmental factors

    Haemophilia

    Volume 20, Issue s4, May 2014, Pages: 87–93, D. Lillicrap, K. Fijnvandraat and E. Santagostino

    Version of Record online : 25 APR 2014, DOI: 10.1111/hae.12412

  16. You have free access to this content
    In non-severe hemophilia A the risk of inhibitor after intensive factor treatment is greater in older patients: a case–control study

    Journal of Thrombosis and Haemostasis

    Volume 8, Issue 10, October 2010, Pages: 2224–2231, C. L. KEMPTON, J. M. SOUCIE, C. H. MILLER, C. HOOPER, M. A. ESCOBAR, A. J. COHEN, N. S. KEY, A. R. THOMPSON and T. C. ABSHIRE

    Version of Record online : 5 AUG 2010, DOI: 10.1111/j.1538-7836.2010.04013.x

  17. You have free access to this content
    Poster Presentations

    Haemophilia

    Volume 23, Issue S2, February 2017, Pages: 29–140,

    Version of Record online : 24 JAN 2017, DOI: 10.1111/hae.13150

  18. You have free access to this content
    Soy Phosphatidylinositol Containing Nanoparticle Prolongs Hemostatic Activity of B-Domain Deleted Factor VIII in Hemophilia A Mice

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 2, February 2015, Pages: 388–395, Krithika A. Shetty, Matthew P. Kosloski, Donald E. Mager and Sathy V. Balu-Iyer

    Version of Record online : 2 APR 2014, DOI: 10.1002/jps.23963

  19. You have free access to this content
    Intensive peri-operative use of factor VIII and the Arg593[RIGHTWARDS ARROW]Cys mutation are risk factors for inhibitor development in mild/moderate hemophilia A

    Journal of Thrombosis and Haemostasis

    Volume 7, Issue 6, June 2009, Pages: 930–937, C.L. ECKHARDT, L.A. MENKE, C.H. VAN OMMEN, J.H. VAN DER LEE, R.B. GESKUS, P.W. KAMPHUISEN, M. PETERS and K. FIJNVANDRAAT

    Version of Record online : 26 MAR 2009, DOI: 10.1111/j.1538-7836.2009.03357.x

  20. You have free access to this content
    HLA-DR-restricted T-cell responses to factor VIII epitopes in a mild haemophilia A family with missense substitution A2201P

    Haemophilia

    Volume 16, Issue 102, May 2010, Pages: 44–55, R. A. ETTINGER, E. A. JAMES, W. W. KWOK, A. R. THOMPSON and K. P. PRATT

    Version of Record online : 23 APR 2010, DOI: 10.1111/j.1365-2516.2008.01905.x